Default company panoramic image
Logo

Hybrid Medical

Urology product, experienced management, strong financial return potential in very large market ($37b-$113b) with very little competition.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Eden Prairie, MN, USA
  • Currency USD
  • Founded October 2010
  • Employees 1
  • Website hybridmedicalmn.com

Company Summary

Invention is treatment for Peyronie’s disease (3%-9% prevalence world adult male population). There is no dominant treatment and no dominant company in this market (one small competitor). Customers are patients with this disease reached through urologists, general practitioners and media. Hybrid Medical profitable with only 0.1% capture of only the US market at the lowest prevalence (3%).

Team

  • Default avatar
    Jeff Twidwell
    MD
    Unconfirmed

    Board Chairman. Dr. Twidwell is a board certified urologist with over 20 years of clinical experience. He has been involved in numerous scientific studies and publications. He is a well-regarded urologist in the Minneapolis, Minnesota area and has been named annually to the “top doctors” list in MPLS-St. Paul Magazine since 1997. Graduate of Creighton University Medical School, urology training at the Naval Hospital in San Diego, California.

  • Default avatar
    Joel Buckley
    Mr.
    Unconfirmed

    Board member, entrepreneur and specialist in building companies and products. He has spent the last 20 years bringing products (both medical and non-medical) and companies to market via his worldwide network including strong infrastructures in Asia. He holds a BA in Marketing/Advertising from the University of St. Thomas (1990).

  • Default avatar
    Harold Hoium
    Mr.
    Unconfirmed

    Board member, CEO. Mr. Hoium has 30 years medical industry experience. He has specific expertise and experience in corporate finance, FDA efforts, international clinical trials, product development, manufacturing, CE mark, marketing and overall corporate strategy. He served as President of a private medical company and prior to that vice-president operations of another medical company. He holds a BA in mathematics and Computer Science and an MBA.

  • Default avatar
    Michael Haukaas
    Dr.
    Unconfirmed

    Intellectual Property Counsel, provider of high quality intellectual property legal services representing the interests of clients in Minnesota, throughout the United States and the world. Dr. Haukaas practices in the chemical and pharmaceutical arts, and has significant experience in drafting and prosecuting patent applications in the United States and throughout the world.

  • Default avatar
    Laurence Levine
    Dr.
    Unconfirmed

    Chief Medical Advisor. Professor of Urology, Rush University, Chicago, Illinois. He has made substantial contribution to the medical press in the form of peer-reviewed articles, abstracts, book chapters, and Internet publications regarding Peyronie’s disease. He is the editor and contributor to the first textbook on Peyronie’s disease (Humana Press, December 2006) and patient guide entitled “Understanding Peyronie’s disease” (Addicus Books, 2007)

  • Default avatar
    Dan Moudry
    Dr.
    Unconfirmed

    Dr. Moudry is a pharmacist and an expert in pharmacy compounding. He provided guidance for Hybrid Medical’s compounding efforts and his company, Moudry RX, can manufacture the compounds required for initial patient testing and early sales. Moudry Rx-Compounding Pharmacy is a full service compounding pharmacy that works with prescribers and patients to customize prescription medications throughout Minnesota. Moudry’s was established in 1929.

Advisors

  • Default avatar
    Tim Duncan; Coleman, Hull and van Vliet, PLLP
    Lawyer
    Unconfirmed